Appello Pharmaceuticals inks $10.5 mln Series A
Nashville-based Appello Pharmaceuticals, a preclinical-stage company focused on treating Parkinson’s disease, has secured $10.5 million in Series A financing. Deerfield Management and Mountain Group Partners led the round.
28 June 2018•1 min read
